Pharmacotherapy Review Course, Pract Exam, and Core Therapeutic Modules Package (No Recert Credit) (Cert # L219217)

ACPE Numbers: Various – see listing below
Pre-Sale Date: 10/27/2021
Content Release Date: 11/24/2021
Expiration Date: 10/25/2022
Activity Type: Application-based
CE Credits: 33.25 contact hours (ACPE only)
Activity Fee: $425 (ASHP member); $625 (non-member)

Activity Overview

This online course provides a robust preparatory curriculum for the pharmacy professional preparing for the Board of Pharmacy Specialties (BPS) Pharmacotherapy Specialty Certification Examination. Designed based on the domains, tasks, and knowledge statements developed by the BPS for the certification examination, this course will help you prepare for the exam by identifying areas needed for in‐depth review of pharmacotherapy issues by:

  • Reviewing pertinent clinical topics and practice skills
  • Providing exam practice questions
  • Listing valuable references for further study

This course is NOT intended for those obtaining recertification credit. To earn recertification credit, please see courses here: http://elearning.ashp.org/catalog/ptherapy-recert 

These activities are part of the ASHP professional development program.

The home study review course will be available February 2, 2022.

 The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. 

These activities are intended for pharmacists who are seeking to update their knowledge and skills commensurate with a board certification examination in the areas listed below. 

This course consists of 10 activities (see table below) and provides up to 16 contact hours of continuing pharmacy education credit. The Review Course includes case-based presentations for application to real-life scenarios, a practice exam along with correct answers, and links to the reference sources, and domains, tasks, and knowledge statements. To help you further prepare, this package includes a compilation of practice questions in the same format and rigor to help you prepare for the BPS Specialty Examination.             


Learning Activity

ACPE Number

Contact Hours

ACPE Expiration Date

Cardiovascular Disease: Primary Prevention Case

0204-0000-21-613-H01-P

1.5

12/4/2024

Cardiovascular Disease: Secondary Prevention Case

0204-0000-21-614-H01-P

1.5

Complex Heart Failure Case

0204-0000-21-615-H01-P

1.5

Providing Safe and Effective Pharmacotherapy: Key Regulatory and Quality Approaches

0204-0000-21-616-H05-P

1.5

Research Methods and Data Analysis / Evidence-based Practice and Resources

0204-0000-21-617-H04-P

2.5

Oncology and Supportive Care Case

0204-0000-21-618-H01-P

1.5

Complex Nursing Home Patient Case

0204-0000-21-619-H01-P

1.5

Complex HIV/AIDS Case

0204-0000-21-620-H02-P

1.5

Complex Pediatric Asthma Case

0204-0000-21-621-H01-P

1.75

Complex Pneumonia Case

0204-0000-21-622-H01-P

1.5

Cardiovascular Disease: Primary Prevention Case
ACPE #: 0204-0000-21-613-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including hypertension, dyslipidemia, chronic kidney disease, diabetes, and obesity.
  • State the Centers for Disease Control and Prevention Advisory Committee on Immunization Practices recommendations for adult immunizations.
  • Determine how to advise a patient on point-of-care testing to measure response to drug therapy.
  • Discuss national benchmarking standards and implications to patient care. 

Cardiovascular Disease: Secondary Prevention Case
ACPE #: 0204-0000-21-614-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including atrial fibrillation (AF), acute coronary syndromes (ACS), and gastroesophageal reflux disease (GERD).
  • Develop a plan to address continuity of care issues.
  • Formulate a medication therapy plan for smoking cessation.
  • Determine how to manage drug – drug and drug-induced disease interactions in a patient with ischemic heart disease.
  • Discuss quality of life in this population.
  • Discuss national benchmarking standards and implications to patient care. 

Complex Heart Failure Case
ACPE #: 0204-0000-21-615-H01-P

  • Select optimal treatment and monitoring for a complex patient-case with multiple conditions, including heart failure, electrolyte disturbances in acute decompensated heart failure, diabetes, and a thyroid disorder.
  • Discuss the medications that should be avoided in heart failure.
  • Identify safety issues in this population.
  • Define inadequate health literacy in this population.

Providing Safe and Effective Pharmacotherapy: Key Regulatory and Quality Approaches
ACPE #: 0204-0000-21-616-H05-P

  • Explain the regulatory and accreditation requirements of a comprehensive medication use program.
  • Describe methods to develop and maintain a medication use system.
  • Discuss technology used to promote safe and effective medication use.
  • Apply national regulations and evidence-based practices for medication safety and quality.
  • Interpret results from pharmacotherapy-related quality improvement activities. 

Research Methods and Data Analysis / Evidence-based Practice and Resources
ACPE #: 0204-0000-21-617-H04-P

  • Analyze biomedical literature with regard to study methodology, statistical analysis, and significance.
  • Explain the use of evidence-based treatment guidelines and protocols.
  • Interpret the biomedical literature and its application to clinical practice.
  • Identify sources of information to use to answer questions in one’s practice, or from patients and healthcare professionals.
  • Explain how to provide education regarding evidence-based practice to current and future health care professionals. 

Oncology and Supportive Care Case
ACPE #: 0204-0000-21-618-H01-P

  • Select the appropriate treatment and monitoring of a complex patient-case with multiple conditions, including breast cancer, febrile neutropenia, and pulmonary embolism.
  • Compare and contrast current breast cancer screening recommendations.
  • Develop a plan to manage pain and nausea/vomiting in a patient with cancer.
  • Discuss safety issues in this population.
  • Discuss adherence issues with oral chemotherapy regimens. 

Complex Nursing Home Patient Case
ACPE #: 0204-0000-21-619-H01-P

  • Select the appropriate treatment for a complex patient-case with multiple conditions, including stroke, depression/anxiety, dementia, chronic obstructive pulmonary disease (COPD) management, osteoarthritis, osteoporosis, and pain.
  • Discuss complementary/alternative medicine and safety issues in this population.
  • Discuss quality improvement initiatives and regulations in the nursing home setting. 

Complex HIV/AIDS Case
ACPE #: 0204-0000-21-620-H02-P

  • Select the appropriate treatment and monitoring of a complex patient-case with multiple conditions, including dyslipidemia, and hepatitis B.
  • Identify and manage common drug interactions experienced by HIV-treated patients.
  • Identify and manage common adverse drug reactions experienced by HIV-treated patients.
  • Determine appropriate medication choices for the treatment and prevention of common opportunistic infections.
  • Discuss quality of life issues in terms of medication therapy for HIV-infected patients.
  • Identify and recommend appropriate resource organizations/groups to assist a specific patient. 

Complex Pediatric Asthma Case
ACPE #: 0204-0000-21-621-H01-P

  • Select optimal treatment and monitoring for a complex patient-case with acute asthma exacerbation, acute otitis media, and seasonal allergies.
  • Apply methods for counseling a patient and/or caregiver in asthma self-management with comprehensive documentation of the patient counseling.
  • Develop a plan for childhood vaccinations in a child who has been delayed in receiving them.
  • Implement principles of shared-decision making and culturally effective care when using complementary/alternative medicine in a pediatric patient. 

Complex Pneumonia Case
ACPE #: 0204-0000-21-622-H01-P

  • Select the appropriate treatment and monitoring for a complex patient-case with multiple conditions, including pneumonia, acute renal insufficiency, sepsis, chronic obstructive pulmonary disease (COPD), and dehydration.
  • Interpret clinical data, including lab, physical examination and vital signs.
  • Determine and prioritize pneumonia-related treatment goals.
  • Determine approaches to manage drug allergies and select next best drug therapy when primary drugs are precluded.
  • Discuss approaches to limiting antimicrobial over use by stewarding antibiotic usage appropriately.
  • Discuss safety issues in patients receiving treatment for pneumonia.

The Core Therapeutic Modules Review Package consists of 16 activities in which faculty review clinical topics and practice skills using a case-based approach. The activities are designed to assist the learner in identifying knowledge gaps in preparation for a pharmacy specialty board examination. In addition to a recorded presentation, each activity includes links to resources for further self-study and a practice test developed in the same format and rigor as the specialty exam.

Learning Activity

ACPE Number

Contact Hours

ACPE Expiration Date

Select Topics in Infectious Diseases: Part 1

0204-0000-19-615-H01-P

1.0

11/20/22

Select Topics in Infectious Diseases: Part 2

0204-0000-19-616-H01-P

1.0

11/20/22

Statistics, Evidence-Based Medicine, and Clinical Trial Design

0204-0000-21-985-H04-P

2.0

05/17/24

Cardiac Arrhythmias and Advanced Cardiac Life Support

0204-0000-20-992-H01-P

1.0

09/23/23

Pharmacotherapy Considerations in the Management of Shock

0204-0000-21-993-H01-P

1.0

09/23/23

Fluid, Electrolytes, and Nutrition 

0204-0000-19-602-H01-P

1.0

09/25/22

Select Topics in Men's Health

0204-0000-20-615-H01-P

1.0

11/25/23

Select Topics in Women's Health

0204-0000-20-616-H01-P

1.0

11/25/23

Select Topics in Neurologic Disorders

0204-0000-19-671-H04-P

1.0

11/20/22

Select Topics in Psychiatric Disorders

0204-0000-21-625-H01-P

1.0

11/24/24

Select Topics in Gastrointestinal Diseases

0204-0000-20-617-H01-P

1.0

11/25/23

Select Topics in Rheumatology

0204-0000-21-626-H01-P

1.0

11/24/24

Diabetes

0204-0000-19-618-H01-P 1.0 11/20/22

Heart Failure

0204-0000-21-627-H01-P 1.0 11/24/24

Selected Topics in Renal Disease

0204-0000-21-628-H01-P 1.0 11/24/24

Patient Education and Health Literacy

0204-0000-21-629-H04-P 1.0 11/24/24

After participating in these CPE activities, learners should be able to:

Select Topics in Infectious Diseases: Part 1
ACPE #: 0204-0000-19-615-H01-P

For the following diseases: C. Difficile infection, skin and soft tissue infections, upper respiratory tract infections, community acquired pneumonia

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment.

Select Topics in Infectious Diseases: Part 2
ACPE #: 0204-0000-19-616-H01-P

For the following diseases: sexually transmitted diseases, urinary tract infections, endocarditis, meningitis

  • Interpret laboratory and diagnostic tests.
  • Formulate the most appropriate treatment and monitoring plans based on patient-specific information and current guidelines.
  • Manage drug-related problems, evaluate response to therapy, and modify patient-specific treatment plans based on follow-up assessment. 

Statistics, Evidence-Based Medicine, and Clinical Trial Design
ACPE #: 0204-0000-21-985-H04-P
At the conclusion of this application-based educational activity, participants should be able to do the following:

  • Determine quality of a study by examining study design, statistical analysis, quality of conclusions, and interpretation of graphs.
  • Determine clinical and statistical significance.
  • Determine if appropriate statistical tests have been used.
  • Determine whether the study applies to a specified patient population.

Cardiac Arrhythmias and Advanced Cardiac Life Support
ACPE #: 0204-0000-20-992-H01-P

  • Interpret signs, symptoms and diagnostic tests for cardiac arrhythmias.
  • Identify drug-related problems, including drug interactions and adverse effects, associated with pharmacotherapy of cardiac arrhythmias.
  • Identify strategies to prevent drug-induced cardiac arrhythmias.
  • Recommend therapy and monitoring for cardiac arrhythmias based on patient-specific information, current guidelines and Advanced Cardiac Life Support (ACLS) guided therapies. 

Pharmacotherapy Considerations in the Management of Shock
ACPE #: 0204-0000-20-993-H01-P

  • Interpret diagnostic and/or laboratory tests, vital signs, and clinical presentation in order to differentiate types of shock (hypovolemic, distributive, cardiogenic).
  • Compare and contrast the pharmacologic agents utilized in shock.
  • Recommend the most appropriate therapy and monitoring based on patient-specific information and current guidelines for the treatment of shock. 

Fluid, Electrolytes, and Nutrition
ACPE #: 0204-0000-19-602-H01-P

  • Interpret laboratory and diagnostic tests to evaluate fluid, electrolyte and nutrition status.
  • Select the appropriate route for nutrition administration, and evaluate if nutrition needs are being met based on patient-specific information and current guidelines.
  • Manage drug-related electrolyte interactions and nutrient interactions.
  • Determine the most appropriate therapy and monitoring in patients with fluid, electrolyte, and nutritional disorders based on patient-specific information and current guidelines.

Select Topics in Men's Health
ACPE #: 0204-0000-20-615-H01-P

  • Recommend appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines for patients with benign prostatic hyperplasia, erectile dysfunction and testosterone deficiency.
  • Explain screening and treatment of osteoporosis in men.
  • Evaluate the role of prostate cancer screening.
  • Select appropriate treatment for patients with prostate cancer. 

Select Topics in Women's Health
ACPE #: 0204-0000-20-616-H01-P

  • Describe pertinent sex-based differences in pharmacodynamics and pharmacokinetics that affect exposure and response to medications.
  • Select health screenings based on patient-specific information for osteoporosis, breast cancer, endometrial cancer, and cervical cancer.
  • Recommend appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines for osteoporosis and menopausal symptoms.
  • Select appropriate contraceptive options, including emergency contraception, based on patient-specific information.
  • Evaluate safety and efficacy of common therapies used during pregnancy and lactation. 

Select Topics in Neurologic Disorders
ACPE #: 0204-0000-19-617-H01-P

For patients with seizure disorders, Parkinson's Disease, migraine and sleep disorders:

  • Evaluate the risks and benefits of drug therapy considering other medication and patient specific factors.
  • Formulate the most appropriate treatment, monitoring and follow-up plans based on patient-specific information and current guidelines.
  • Manage drug-related problems and evaluate response to therapy. 

Select Topics in Psychiatric Disorders
ACPE #: 0204-0000-21-625-H01-P

For patients with bipolar, schizophrenia, anxiety disorders, post-traumatic stress disorder, and/or substance abuse disorder:

  • Interpret basic diagnostic factors, clinical presentation, and target symptoms of selected psychiatric disorders.
  • Formulate the most appropriate treatment, monitoring, and follow-up plans based on patient-specific information and current guidelines.
  • Evaluate drug-related problems and response to therapy. 

Select Topics in Gastrointestinal Diseases
ACPE #: 0204-0000-20-617-H01-P

For patients with nausea, vomiting, inflammatory bowel disease, gastroesophageal reflux disease, or peptic ulcer disease:

  • Recommend appropriate treatment and monitoring, based on drug-specific variables, patient-specific information and clinical practice guidelines.
  • Evaluate drug-related problems and response to therapy.
  • Recommend modifications of patient-specific treatment plans based on follow up assessment. 

Select Topics in Rheumatology
ACPE #: 0204-0000-21-626-H01-P

For patients with rheumatoid arthritis, osteoarthritis and gout:

  • Formulate the most appropriate treatment and monitoring, based on drug-specific variables, patient-specific information and clinical practice guidelines.
  • Evaluate drug-related problems and response to therapy.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow up assessment. 

Diabetes
ACPE #: 0204-0000-19-618-H01-P

  • Interpret diagnostic and/or laboratory tests in patients with diabetes.
  • Formulate the most appropriate treatment and monitoring plans, based on patient-specific information and current guidelines for patients with diabetes.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow-up assessment in patients with diabetes. 

Heart Failure
ACPE #: 0204-0000-21-627-H01-P

  • Interpret diagnostic and/or laboratory tests, vital signs and clinical presentation in patients with heart failure.
  • Formulate the most appropriate treatment and monitoring plans, based patient-specific information and current guidelines for patients with heart failure.
  • Recommend appropriate modifications of patient-specific treatment plans based on follow up assessment in patients with heart failure.

Selected Topics in Renal Disease
ACPE #: 0204-0000-21-628-H01-P

  • For patients with acute kidney injury and chronic kidney disease determine the most appropriate treatment and monitoring based on drug characteristics, patient-specific factors, and current clinical practice guidelines.
  • Manage drug dosing and drug-related complications in patients receiving renal replacement therapy.
  • Identify appropriate modifications to the treatment plans based on follow-up assessment to optimize outcomes. 

Patient Education and Health Literacy
ACPE #: 0204-0000-21-629-H04-P

  • Assess considerations for communicating pharmacotherapy plans to various patient populations, including pediatric patients and geriatric patients, using universal health literacy precautions.
  • Evaluate methods for educating patients and caregivers on safe and appropriate use of medications and devices.

Faculty Bios

Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP*
Professor
Sullivan University College of Pharmacy and Health Sciences
Cardiology Clinical Pharmacy Specialist
Jewish Hospital Rudd Heart & Lung Center – U of L Health
Louisville, Kentucky 

Snehal H. Bhatt, Pharm.D., BCPS-AQ Cardiology, FASHP, AACC*
Professor of Pharmacy Practice
MCPHS University
Clinical Pharmacist
Beth Israel Deaconess Medical Center
Boston, Massachusetts 

Sarah Caulfield, Pharm.D., BCOP
Clinical Pharmacy Specialist - Medical Oncology
Emory Healthcare - Winship Cancer Institute
Atlanta, Georgia 

Kalin Clifford, Pharm.D., BCPS, BCGP
Associate Professor of Pharmacy Practice, Division of Geriatrics and Pediatrics
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Clinical Pharmacy Specialists, Geriatrics & Extended Care
VA North Texas Health Care System
Dallas, Texas 

Brooklyn Cobb, Pharm.D., BCPS
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy, University of the Sciences
Philadelphia, Pennsylvania
Clinical Pharmacy Specialist - Ambulatory Care
Cooper University Hospital
Camden, New Jersey 

Lourdes Cross, Pharm.D., BCACP, CDE
Assistant Professor
Sullivan University College of Pharmacy and Health Sciences
Louisville, Kentucky
Clinical Pharmacy Specialist
University of Louisville Hospital
Louisville, Kentucky

Ilya Danelich, Pharm.D., BCPS, BCCP
Clinical Coordinator; Cardiology Clinical Pharmacy Specialist
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania 

Karrie L. Derenski, Pharm.D., BCNSP, BCCCP, CNSC
Clinical Supervisor, Director PGY 2 Pharmacy Residency - Critical Care, Department of Pharmacy
Cox Health
Springfield, Missouri 

Heather Draper, Pharm.D., BCPS
Clinical Specialist, Emergency Medicine
Mercy Health Saint Mary's
Grand Rapids, Michigan 

Jessica Farrell, Pharm.D.
Associate Professor
Albany College of Pharmacy and Health Sciences
Clinical Pharmacist
The Center for Rheumatology
Albany, New York

Stuart T. Haines, Pharm.D., BCPS, BCACP, FASHP
Professor and Director
Professional Development
University of Mississippi School of Pharmacy
Jackson, Mississippi 

Brian M. Hoff, Pharm.D., BCPS, BCIDP
Infectious Diseases Pharmacist
Department of Pharmacy
Northwestern Memorial Hospital
Chicago, Illinois 

Meredith Keisler, Pharm.D., BCOP, CPP
Clinical Pharmacist Practitioner - Oncology Palliative Care
UNC Health
Chapel Hill, North Carolina 

Patricia C. Kienle, B.S.Pharm., MPA, BCSCP, FASHP
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Katelin Lisenby, Pharm.D., BCPS
Assistant Clinical Professor
Auburn University Harrison School of Pharmacy
Tuscaloosa, Alabama 

Mei T. Liu, Pharm.D., BCPP
Clinical Assistant Professor
Ernest Mario School of Pharmacy
Rutgers, The State University of New Jersey
Piscataway, New Jersey
Psychiatry Clinical Pharmacist
Penn Medicine Princeton House Behavioral Health
Princeton, New Jersey 

Jill Morgan, Pharm.D., BCPS, BCPPS
Professor and Chair
University of Maryland School of Pharmacy
Baltimore, Maryland 

Nicholas Owens, Pharm.D., BCACP, BCPS
Assistant Professor of Clinical Pharmacy
Philadelphia College of Pharmacy at University of the Sciences
Philadelphia, Pennsylvania

Krystal L. Moorman, Pharm.D., BCPS
Assistant Clinical Professor, Pharmacotherapy
University of Utah College of Pharmacy
Clinical Pharmacist
University of Utah Hospitals and Clinics
Salt Lake City, Utah 

Marc H. Scheetz, Pharm.D., M.Sc., BCPS-AQID, FCCP
Professor of Pharmacy and Pharmacology; Director of Pharmacometrics Center of Excellence
Midwestern University
Downers Grove, Illinois
Infectious Diseases Pharmacist
Northwestern Memorial Hospital
Chicago, Illinois 

Douglas Slain, Pharm.D., BCPS, AQ-ID*
Professor and Infectious Diseases Clinical Specialist
West Virginia University
Morgantown, West Virginia 

Paul M. Szumita, Pharm.D., BCCCP, BCPS, FASHP, FCCM
Clinical Pharmacy Practice Manager
Brigham & Women's Hospital
Boston, Massachusetts 

Trent G. Towne, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Department of Pharmacy Practice
Manchester University, College of Pharmacy, Natural and Health Sciences
Clinical Pharmacist, Infectious Disease
Department of Pharmacy
Parkview Health System
Fort Wayne, Indiana 

Laura Waite, Pharm.D., BCPS, CLS, BC-ADM
Associate Professor of Clinical Pharmacy, Director of Student Recruitment and Engagement
Middle States Commission on Higher Education Self-Study Co-Chair
Philadelphia College of Pharmacy
University of the Sciences
Philadelphia, Pennsylvania 

Kristin Watson, Pharm.D., BCCP
Associate Professor
University of Maryland
School of Pharmacy
Baltimore, Maryland 

Jon P. Wietholter, Pharm.D, BCPS
Clinical Associate Professor, West Virginia University School of Pharmacy
Adjunct Associate Professor, West Virginia University School of Medicine
Internal Medicine Clinical Pharmacist, WVU-Medicine Ruby Memorial Hospital
Morgantown, West Virginia

*Content Matter Experts

Anna M. Jackson, Pharm.D., BCPS
Tony Martin, Pharm.D., M.B.A.
Susan R. Dombrowski, M.S., R.Ph.

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Patricia Kienle: Cardinal Health/Employee; CriticalPoint LLC/Instructor; USP/Volunteer; ASHP/Author
  •  Marc Scheetz: Merck/Grant to MWU; Abbvie/Consulting; Supertrans Medical/Consulting and Contracts; Nevakar/Consulting and Contracts; Allecra/Contract
  • Jessica Farrell: Pfizer, speaker bureau; Abbvie, speaker bureau; Cumberland Pharmaceuticals, consultant

All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Activities can be completed in any order. Each activity consists of audio, video, and/or PDFs and evaluations. Learners must review all content and complete the evaluations to receive continuing pharmacy education credit for each activity. 

Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity. 

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.